CA-125:
What Is It? What Is the Normal Range? and How Are the Results Interpreted?
CA-125 (Cancer Antigen 125) is a protein measured in a blood test and used as a tumor marker. The test is primarily used to monitor ovarian cancer, although it may also be relevant in several other medical conditions.
The CA-125 test is generally not used for the initial diagnosis of cancer. Its main role is monitoring the course of the disease over time and evaluating response to treatment.
Physicians use this test to understand whether a treatment is working, whether the disease is stable, or whether there may be early signs of recurrence.
What Is the Normal CA-125 Level?
In most laboratories, the normal CA-125 level is considered to be up to 35 units per milliliter (U/ml).
However, it is important to understand that an elevated level does not necessarily indicate cancer. Several non-cancerous conditions can cause an increase in CA-125.
For example
- Endometriosis
- Pelvic inflammation
- Ovarian cysts
- Liver disease
- Pregnancy
- During menstruation
Therefore, the test results are always interpreted in the context of the patient’s overall medical condition and together with additional tests.
In Which Diseases Is CA-125 Monitoring Used?
CA-125 testing is mainly used for monitoring
- Ovarian cancer
- Peritoneal cancer
- Fallopian tube cancer
- Occasionally other oncologic conditions according to the physician’s clinical judgment
In many cases, the test is performed every few weeks or months during treatment.
How Are CA-125 Results Interpreted?
When physicians evaluate CA-125 results, they usually focus not on a single value but on the trend over time.
For example
Test 1 18
Test 2 32
Test 3 10
Test 4 20
Changes such as these may occur during treatment or between treatment cycles. For this reason, physicians interpret the results together with additional examinations such as CT or PET-CT imaging.
In some cases, a significant decrease in CA-125 levels may indicate a positive response to treatment.
How to Understand a CA-125 Trend
During follow-up, several types of CA-125 trends may be observed
Decreasing values
May indicate that the treatment is working and the disease is responding.
Stable values over time
May suggest that the disease is under control.
Gradual increase
May raise suspicion of disease progression and usually leads to additional evaluation.
Small fluctuations between tests
Minor changes between tests are common and are not always clinically significant.
Important to Know
The CA-125 test is a monitoring tool and is not a stand-alone diagnostic test for cancer.
Physicians interpret the results together with other clinical information such as
- Imaging tests CT MRI PET-CT
- Additional blood tests
- Genetic or molecular tests
- The patient’s clinical condition
Only by combining all available data can physicians obtain a complete understanding of the patient’s disease status.
